Search
for
Sort by
Research 31–60 of 1000+
- Androgens and androgen receptor action in skin and hair follicles
- Finasteride in the treatment of hirsutism: new therapeutic perspectives
- An appraisal of laboratory models of androgenetic alopecia: A systematic review
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Improvement in Androgenetic Alopecia (Stage V) Using Topical Minoxidil in a Retinoid Vehicle and Oral Finasteride
- Markers of peripheral androgen action in vivo and in vitro
- Recent advances in oxasteroids chemistry
- Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
- Androgen binding profiles of two distinct nuclear androgen receptors in Atlantic croaker (Micropogonias undulatus)
- 5α-Reductases in Human Physiology: An Unfolding Story
- Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring
- 3α-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- 5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Urinary steroids in women with androgenic alopecia
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Inhibition of Rat 5<i>α</i>-Reductase Activity and Testosterone-Induced Sebum Synthesis in Hamster Sebocytes by an Extract of<i>Quercus acutissima</i>Cortex
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES